Alphamab Oncology

HKEX:9966.HK

2.53 (HKD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Omzet 82.309136.465113.27653.569146.0210002.4342.5580-1.0810.34600000
Kosten van de omzet 22.07233.16529.38714.823.0280000000000000
Brutowinst 60.237103.383.88938.749142.9930002.4342.5580-1.0810.34600000
Brutowinstmarge 0.7320.7570.7410.7230.9790001101100000
Onderzoek- en ontwikkelingskosten 212.843194.681251.839216.399249.414231.947197.517133.724110.90255.75241.66439.03126.57716.40216.40213.30513.30513.305
Algemene en administratieve kosten 46.09433.24442.67444.09739.1238.13137.62940.57993.07524.66138.57416.6179.243.3293.3291.6581.6581.658
Verkoop- en marketingkosten -0.1870.1870.0040.165-0.0360.335-0.020.020000000000
Verkoop-, algemene en administratieve kosten 46.13233.43142.67844.26239.08438.46637.60940.59993.07524.66138.57416.6179.243.3293.3291.6581.6581.658
Overige kosten 000000000-287.521-287.521-287.521-56.815-56.815-56.815-23.226-23.226-23.226
Bedrijfskosten 262.068173.925276.956191.064295.362274.673349.142131.458794.00869.47-207.284100.542100.272-37.084-37.084-8.263-8.263-8.263
Bedrijfsresultaat -198.7-124.625-210.624-221.747-145.541-270.078-235.146-174.303-201.543-77.855-207.284-56.729-35.471-37.084-37.084-8.263-8.263-8.263
Bedrijfsresultaat ratio -2.414-0.913-1.859-4.139-0.997000-82.803-30.436052.478-102.51700000
Totaal overige inkomsten en kosten netto 27.96984.76332.21174.4380.4882.714-89.5271.203-572.41219.07-0.902-45.862-64.571-13.574-13.574-7.943-7.943-7.943
Inkomen voor belasting -170.731-39.862-178.413-147.309-145.053-267.364-324.666-103.1-773.955-58.785-208.185-102.591-100.042-50.658-50.658-16.207-16.207-16.207
Inkomen voor belasting ratio -2.074-0.292-1.575-2.75-0.993000-317.977-22.981094.904-289.13900000
Belastingkosten 0000000000.9020.9020.9020.3770.3770.3770.0020.0020.002
Nettowinst -170.731-39.862-178.413-147.309-145.053-267.364-324.666-103.1-773.955-58.785-209.087-97.892-51.951-51.035-51.035-16.209-16.209-16.209
Nettowinstmarge -2.074-0.292-1.575-2.75-0.993000-317.977-22.981090.557-150.14700000
WPA (Winst Per Aandeel) -0.18-0.042-0.19-0.16-0.15-0.29-0.35-0.11-1.39-0.12-0.39-0.21-0.21-0.057-0.057-0.018-0.018-0.018
Verwaterde WPA -0.18-0.042-0.19-0.16-0.15-0.29-0.35-0.11-1.39-0.088-0.39-0.21-0.21-0.057-0.057-0.018-0.018-0.018
EBITDA -168.52-99.021-186.006-205.823-130.605-256.493-224.713-165.756-200.059-77.511-204.34-56.52-35.414-35.444-35.444-8.135-8.135-8.135
EBITDA ratio -2.047-0.726-1.642-3.842-0.894000-82.194-30.301052.285-102.35300000